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Introduction. Pseudohypoparathyroidism type 1a is caused by GNAS mutations leading to target organ resistance to multiple
hormones rather than parathyroid hormone, resulting not only in hypocalcemia, but also in Albright’s hereditary osteodystrophy
phenotype. Materials and Methods. DNA sequencing of the GNAS gene identified a novel heterozygous mutation in peripheral
blood leukocytes in the family presented in this case report. Results. We present a case of a 25-year-old woman with
pseudohypoparathyroidism type 1a admitted with seizures, whose family presents an autosomal dominant transmission of a novel
heterozygous GNAS mutation (c.524 530+3del). Conclusion. Pseudohypoparathyroidism type 1a is mostly caused by inactivating
GNAS mutations that have been gradually reported in the literature that lead to a typical and complex clinical phenotype and
resistance to multiple hormones. The deletion caused by the mutation identified in the presented case has not been reported
previously.
1. Introduction
Pseudohypoparathyroidism (PHP) is a rare disorder charac-
terized by target organ resistance to parathyroid hormone
(PTH), resulting in hypocalcemia and hyperphosphatemia
[1, 2]. PHP type 1a is due to a heterozygous loss of function
of the alpha subunit of a G protein (Gs𝛼), due to a GNAS
mutation on the maternal allele of the chromosome 20q13.3,
with autosomal dominant inheritance [3, 4].This intracellular
protein is responsible for the production of cyclic AMP
(cAMP) in response to PTH, and the reduced G protein
activity is the molecular basis for hormone resistance in this
disorder [3]. PHP type 1a is characterized by the expression
of the Gs𝛼 isoform only of the paternal GNAS gene, with
resistance to other hormones rather than PTH and by the
phenotype of Albright’s hereditary osteodystrophy (AHO)
with round facies, short stature, obesity, subcutaneous ossifi-
cations, brachydactyly, and in some cases mental retardation
[3–5].
2. Case Presentation
A25-year-oldwomanwas admitted to the Emergency Service
after a generalized tonic-clonic seizure. She had a history
of hypoparathyroidism, hypothyroidism, and mild retar-
dation, being medicated with calcium carbonate 9000mg
plus cholecalciferol 2400U/day, levothyroxine 0,1mg/day,
and desogestrel/ethinylestradiol 0,15/0,02mg/day. She had
multiple hospital admissions with seizures because of lack of
therapeutic compliance and had repeatedly refused further
investigation of the underlying disease or regular outpatient
follow-up.
Physical examination showed a short stature, obesity
(BMI 35 kg/m2), dental hypoplasia, round facies, and brachy-
dactyly of the fourth and fifth metacarpals (Figure 1) and
metatarsals. At admission she was conscious, with Glasgow
Coma Scale of 15 points, had normal vitals (blood pressure
120/60mmHg; heart rate 68 beats perminute; respiratory rate
16 cycles per minute; O
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Figure 1: Radiography of both hands, revealing brachydactyly of the fourth and fifth metacarpals.
(a) (b)
Figure 2: Axial cuts of CT scan, revealing diffuse subcortical frontoparietal (a) and striatum capsularis and thalamus calcifications (b).
no fever (temperature 36,7∘C). She had positive Chovstek
and Trousseau signs, without tetany. Her pulmonary and
cardiac auscultations were normal. The neurologic examina-
tion revealed no focal signs, no photophobia, and negative
Kernig’s and Brudzinski’s signs.
Laboratory tests revealed severe hypocalcemia (serum
calcium with albumin correction 5,5mg/dL; normal range
(NR) 8,6–10,0mg/dL), hyperphosphatemia (6,7mg/dL;
NR 2,7–4,5mg/dL), and high PTH (160,1 pg/mL; NR
10–65 pg/mL), with normal vitamin D (37 ng/mL; NR
30–100 ng/mL) and low calcium in the 24-hour urine
collection (23,9mg/24 h; NR 100–300mg/24 h). The thyroid-
stimulating hormone (TSH) was normal (4,04mIU/L; NR
0,27–4,2mIU/L), with free thyroxine of 16,53 pmol/L (NR
1,17–21,7 pmol/L). The CT scan revealed diffuse subcortical
frontoparietotemporal, striatum capsularis, and thalamus
calcifications (Figure 2), without other changes.
Her family history revealed an aunt and a sister with
clinical diagnosis hypoparathyroidism and AHO, as well as
two nephews, without further investigation, and the presence
of AHO in her mother, without further investigation; her
older brother had a fatal respiratory infection in infancy. Our
subject’s one-year-old son hadAHOandhypoparathyroidism
as well. Considering this presentation, we assumed that all
individuals should have pseudohypoparathyroidism as well.
Based on the clinical features of AHO plus the pseudohy-
poparathyroidism with hypocalcemia, hyperphosphatemia,
and tissue resistance to the increased level of PTH, she was
diagnosed with PHP type 1a. Facing her family history and
to support our diagnosis, and after explaining to the patient
the implications of the diagnosis for both her and her child,
we were able to obtain consent to further investigation that
she had refused before. Therefore, we performed a genetic
study with DNA analysis of the GNAS gene extracted from
peripheral blood leukocytes with identification of the novel
mutation c.524 530+3del (p.Gln176Serfs∗7) in heterozygos-
ity, in the location 20q13.32-exon 6, both in our patient and
in her son. The genogram (Figure 3) suggests an autosomal

























Figure 3: Genogramof the subject’s family. Our subject is identified by the black arrow-head. y: year(s) old; PHP: pseudohypoparathyroidism;
AHO: Albright’s hereditary osteodystrophy.
dominant inheritance with maternal derived transmission.
We were not able to perform DNA sequencing of the GNAS
gene of any other family member.
3. Discussion
PHP type 1a is caused mostly by maternal heterozygous inac-
tivating mutations in the GNAS gene leading to a complex
clinical phenotype that includes resistance to multiple hor-
mones, intellectual disability, andAHO [1, 4].This phenotype
is most likely explained by the fact that some tissues (thyroid,
pituitary, renal proximal tubules, and gonads) express Gs𝛼
predominantly from the maternal allele, while the paternal
is silenced through yet unknown mechanisms. In PHP type
1a, inactivating mutations on the maternal allele will result in
little or no production of this subunit with haploinsufficiency
of Gs𝛼, resulting in multiple hormone resistance within
these specific tissues [3]. The resistance to PTH leads to
hypocalcemia and hyperphosphatemia, and as calcium plays
an essential role in stabilizing the cell membrane, there is an
increased risk of seizures, as happened with our patient [2].
Lemos and Thakker [6] identified 343 kindreds with
heterozygous Gs-alpha germline mutations in the literature
that yielded a total of 176 different germline mutations,
without unknown prevalence, but with some acknowledged
mutational hot spots, as exon 1 and codons 189-190 in exon
7. A novel mutation was identified in both our patient and
her son in exon 6. The genogram suggests the autosomal
dominant maternal transmission to both our patient and her
sister. However, we were not able to test our patient’s relatives
which was a limitation in this case.
In conclusion, there are over 340 reported GNAS muta-
tions leading to PHP type 1a [1], and the identification of
the causative mutation in the index case may be useful for
screening other family members avoiding late diagnosis or
misdiagnosis and for prenatal counseling both to our patient
and to her sister and in the future for our patient’s son and
nephews.
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